Visa Inc. (LON:0QZ0)
339.50
-9.85 (-2.82%)
At close: Aug 1, 2025
Revance Therapeutics Market Cap
Visa Inc. has a market cap or net worth of 503.32 billion as of August 1, 2025. Its market cap has increased by 7.72% in one year.
Market Cap
503.32B
Enterprise Value
508.48B
Revenue
28.39B
Ranking
n/a
PE Ratio
34.38
Stock Price
$339.50
Market Cap Chart
Since March 19, 2008, Visa Inc.'s market cap has increased from 5.52B to 503.32B, an increase of 9,017.24%. That is a compound annual growth rate of 29.65%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 31, 2025 | 503.32B | 1.73% |
Dec 31, 2024 | 494.78B | 20.82% |
Dec 29, 2023 | 409.50B | 15.83% |
Dec 30, 2022 | 353.54B | 5.52% |
Dec 31, 2021 | 335.03B | -1.43% |
Dec 31, 2020 | 339.90B | 11.97% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 173.02B |
HSBC Holdings | 168.02B |
Shell | 158.49B |
Unilever | 110.42B |
British American Tobacco p.l.c. | 86.00B |
Rolls-Royce Holdings | 83.88B |
Rio Tinto Group | 79.46B |
RELX PLC | 71.37B |